tirzepatide insurance approval FDA for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly is now offering

Night shift workers should choose their injection day based on their sleep schedule rather than the calendar

Our comprehensive Tirzepatide weight loss program provides everything needed for successful, medically supervised weight loss with flexible options designed to fit your lifestyle and preferences

Semaglutide still delivers substantial weight loss and remains an effective option, particularly for individuals who prefer a longer track record and broader brand availability

A study shows that when used with lifestyle changes, the weekly 2.4 mg dose of semaglutide reduced 10-15% of body weight compared to the placebo, which reduced body weight by only 2-3%